Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1066 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME
André J. Scheen
Diabetes Research and Clinical Practice.2016;121()204
[DOI]
2Reappraisal of the diuretic effect of empagliflozin in the EMPA-REG OUTCOME trial: Comparison with classic diuretics
A.J. Scheen
Diabetes & Metabolism.2016;42(4)224
[DOI]
3Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME
A.J. Scheen,P. Delanaye
Diabetes & Metabolism.2017;43(2)99
[DOI]
4Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
Sanjay Kalra,Arpit Jain,Jignesh Ved,AG Unnikrishnan
Indian Journal of Endocrinology and Metabolism.2016;20(5)725
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal